Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Viasat (VSAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Viasat — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while Viasat trades at $69.48 (market cap $9.76B). The key difference: Viasat is far larger — about 2.1× Definium Therapeutics Inc. Common Shares's market cap, and Definium Therapeutics Inc. Common Shares is more actively traded (1,966,636 versus 1,739,997). Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Viasat for 10 Days on average.
| DFTX | VSAT | |
|---|---|---|
Market Cap | $4.71B | $9.76B |
Volume | 1,966,636 | 1,739,997 |
Sector | Health | Technology |
52-Week High | $48.45 | $89.81 |
52-Week Low | $10.68 | $30.35 |
Typical Hold Time | 0 Days | 10 Days |
Enterprise Value | $3.67B | $14.95B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Viasat
Viasat provides satellite communications and connectivity services for aviation, maritime, government, enterprise, and consumer markets. Its network combines satellite and ground infrastructure to deliver connectivity in remote and mobile environments.
Read more on VSAT →
